| Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. | |
| | |
MedLine Citation:
|
PMID: 14579097 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Imaging of amino acid transport in brain tumours is more sensitive than fluorine-18 2-fluoro-deoxyglucose positron emission tomography (PET). The most frequently used tracer in this field is carbon-11 methionine (MET), which is unavailable for PET centres without a cyclotron because of its short half-life. The purpose of this study was to evaluate the performance of 3,4-dihydroxy-6-[(18)F]fluoro-phenylalanine (FDOPA) in this setting, in comparison with MET. Twenty patients with known supratentorial brain lesions were referred for PET scans with FDOPA and MET. The diagnoses were 18 primary brain tumours, one metastasis and one non-neoplastic cerebral lesion. All 20 patients underwent PET with FDOPA (100 MBq, 20 min p.i.), and 19 of them also had PET scans with MET (800 MBq, 20 min p.i.). In all but one patient a histological diagnosis was available. In 15 subjects, histology was known from previous surgical interventions; in five of these patients, as well as in four previously untreated patients, histology was obtained after PET. In one untreated patient, confirmation of PET was possible solely by correlation with MRI; a histological diagnosis became available 10 months later. MET and FDOPA images matched in all patients and showed all lesions as hot spots with higher uptake than in the contralateral brain. Standardised uptake value ratios, tumour/contralateral side (mean+/-SD), were 2.05+/-0.91 for MET and 2.04+/-0.53 for FDOPA (NS). The benign lesion, which biopsy revealed to be a focal demyelination, was false positive, showing increased uptake of MET and FDOPA. We conclude that FDOPA is accurate as a surrogate for MET in imaging amino acid transport in malignant cerebral lesions for the purpose of visualisation of vital tumour tissue. It combines the good physical properties of (18)F with the pharmacological properties of MET and might therefore be a valuable PET radiopharmaceutical in brain tumour imaging. |
| | |
Authors:
|
Alexander Becherer; Georgios Karanikas; Monica Szabó; Georg Zettinig; Susanne Asenbaum; Christine Marosi; Christine Henk; Patrick Wunderbaldinger; Thomas Czech; Wolfgang Wadsak; Kurt Kletter |
Related Documents
:
|
19461037 - The performance of mri-based cerebral blood flow measurements in acute and subacute str... 17295617 - Pet imaging in the photosensitive baboon: case-controlled study. 18555547 - Correlation between pretreatment fdg-pet biological target volume and anatomical locati... 22237147 - A pragmatic contouring guideline for salivary gland structures in head and neck radiati... 23652207 - Correlation between morphological and functional liver volume in each sector using inte... 10696027 - Dynamic contrast-enhanced mr angiography and mr imaging of the carotid artery: high-res... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Studies Date: 2003-07-23 |
Journal Detail:
|
Title: European journal of nuclear medicine and molecular imaging Volume: 30 ISSN: 1619-7070 ISO Abbreviation: Eur. J. Nucl. Med. Mol. Imaging Publication Date: 2003 Nov |
Date Detail:
|
Created Date: 2003-10-27 Completed Date: 2004-08-06 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 101140988 Medline TA: Eur J Nucl Med Mol Imaging Country: Germany |
Other Details:
|
Languages: eng Pagination: 1561-7 Citation Subset: IM |
Affiliation:
|
Department of Nuclear Medicine, Medical School, University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. alexander.becherer@univie.ac.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Brain Neoplasms / pathology, radionuclide imaging* Dihydroxyphenylalanine / analogs & derivatives*, diagnostic use* Female Humans Male Methionine / diagnostic use* Middle Aged Radiopharmaceuticals / diagnostic use Reproducibility of Results Sensitivity and Specificity Tomography, Emission-Computed / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 58576-49-1/carbon-11 methionine; 63-68-3/Methionine; 63-84-3/Dihydroxyphenylalanine; 75290-51-6/fluorodopa F 18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral in...
Next Document: From PET detectors to PET scanners.